Last kr3.39 SEK
Change Today +0.05 / 1.50%
Volume 273.1K
As of 7:30 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carl-Henrik Heldin Ph.D.

Director, Kancera AB
AgeTotal Calculated CompensationThis person is connected to 42 board members in 3 different organizations across 3 different industries.

See Board Relationships
61--

Background*

Mr. Carl-Henrik Heldin, Ph.D, serves as an Advisor of Kolltan Pharmaceuticals (USA). Mr. Heldin serves as an Advisor of MolMed SpA (Italy). He has a solid reputation and extensive network from assignments as advisor to several academic institutions including German Cancer Research Center, Heidelberg, European Institute of Oncology, Milan, European Molecular Biology Laboratory, Heidelberg and the Max Planck Institute in Martinsried. He serves as a Director for Kancera ...

Read Full Background

Corporate Headquarters*

Karolinska Institutet Science Park
Solna, Stockholm County 171 48

Sweden

Phone: 46 8 50 12 60 80
Fax: --

Board Members Memberships*

Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KAN:SS kr3.39 SEK +0.05

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANCERA AB, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.